DavidCrittendenHooperMD
Infectious Disease • Boston, MAProfessor of Medicine, Massachusetts General Hospital
Are you Dr. Hooper?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Grj 5
Boston, MA 02114Phone+1 617-726-3812Fax+1 617-726-7416
Summary
- Dr. David Hooper, MD is an infectious disease specialist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Massachusetts General Hospital and is a Professor of Medicine at Massachusetts General Hospital.
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1978 - 1981- Massachusetts General HospitalResidency, Internal Medicine, 1973 - 1975
Washington University in St. Louis School of MedicineClass of 1973
Certifications & Licensure
MA State Medical License 1975 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- 129 citationsMetallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline.Sara E Boyd, David M. Livermore, David C. Hooper, William W. Hope
Antimicrobial Agents and Chemotherapy. 2020-09-21 - 816 citationsHospital-Acquired Infections Due to Gram-Negative BacteriaAnton Y. Peleg, David C. Hooper
The New England Journal of Medicine. 2010-05-12 - 326 citationsDifficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to Al...Sameer S Kadri, Jennifer Adjemian, Yi Ling Lai, Alicen B Spaulding, Emily Ricotta
Clinical Infectious Diseases. 2018-11-28
Authored Content
- Chromosomal Mutations That Accompany Qnr in Clinical Isolates of Escherichia ColiJanuary 2018
Press Mentions
Is It Time to Wear Masks Again?July 26th, 2021- Mass General Central Flu Clinic Adapts to COVID-19March 18th, 2021
- Where Has the Flu Gone? Influenza Activity Hasn’t Been This Low in Memory and COVID Has a Lot to Do with ItFebruary 13th, 2021
- Join now to see all
Grant Support
- Quinolone And Multidrug Resistance In Staphylococcus AureusNational Institute Of Allergy And Infectious Diseases2008–2012
- Harvard-Wide Program On Antibiotic ResistanceNational Institute Of Allergy And Infectious Diseases2011
- Antimicrobials And Efflux Pumps In Staphylococcus Aureus InfectionNational Institute Of Allergy And Infectious Diseases2011
- Plasmid-Mediated Quinolone ResistanceNational Institute Of Allergy And Infectious Diseases2009–2011
- Mechanism And Spread Of Qnr-Mediated ResistanceNational Institute Of Allergy And Infectious Diseases2004–2008
- Quinolone Resistance Mechanisms In Staphylococcus AureusNational Institute Of Allergy And Infectious Diseases1995–2007
- Bacterial Quinolone Resistance By Altered Drug UptakeNational Institute Of Allergy And Infectious Diseases1989–1991
- Mechanisms Of Action And Resistance To Quinolone AgentsNational Institute Of Allergy And Infectious Diseases1986–1988
